New Zealand markets closed

Statera Biopharma, Inc. (STAB)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00030.0000 (0.00%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0003
Bid0.0000 x 1100
Ask0.0000 x 3000
Day's range0.0003 - 0.0003
52-week range0.0003 - 0.3047
Avg. volume50,274
Market cap21,425
Beta (5Y monthly)0.14
PE ratio (TTM)N/A
EPS (TTM)-2.3600
Earnings date26 Oct 2023 - 30 Oct 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs

    FORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (OTCPK:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Worksite Labs, Inc. ("WSL"), setting out the initial proposed terms and conditions pursuant to which the Company and Worksite Labs intend to affect a busine